title: The new drugs advent: clinical or economic outcomes?
authors.affiliation: Clinical Trials Unit, National Cancer Institute of Naples, Naples, Italy.
authors.forename: E
authors.initials: E
authors.lastname: De Maio
authors.forename: F
authors.initials: F
authors.lastname: Perrone
authors.forename: G
authors.initials: G
authors.lastname: Bisagni
authors.forename: C
authors.initials: C
authors.lastname: Boni
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D008495:Medical Oncology; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents